Table 2.
Care and clinical characteristics.
| Variable | Value |
|---|---|
| Type of consultation, n (%) | Results of 1st visit = 49 (11) |
| Successive consultations = 418 (89) | |
| Type of review, na | Clinical assessment = 354 |
| Delivery of results = 338 | |
| Adjustment to treatment = 38 | |
| Years of follow-up in rheumatology, mean (SD) | 8.03 (2.5) |
| Number of visits per year, mean (SD) | 2 (3.5) |
| Time (months ) from last review, media (SD) | 6.19 (3.5) |
| Rheumatic disease attended, nb | OA/STR = 199 |
| OP = 141 | |
| RA = 99 | |
| PsA = 37 | |
| AS = 56 | |
| FM = 37 | |
| Gout = 20 | |
| SLE = 17 | |
| Col = 27 | |
| RPM = 15 | |
| ACPD = 5 | |
| Biologic therapy control, n (%) | 98 (21) |
| No changes in treatment in RTC, n (%) | 379 (81) |
| Duration of the RTC (minutes), mean (range) | 9.64 (3−30) |
| Satisfaction with RTC NVS patient: mean (SD) | 8.62 (4) |
| Satisfaction with RTC NVS doctor: mean (SD) | 8.84 (.5) |
| Would they repeat RTC? Patient, yes, n (%) | 391 (84) |
| Would they repeat RTC? Doctor, yes, n (%) | 431 (92) |
ACPD: Arthropathy from calcium pyrophosphate deposit; AS: Ankylosing Spondylitis, Col: Other colagenosis not SLE; FM: Fibromyalgia; OA/STR: Osteoarthritis/Soft tissue rheumatism; OP: Osteoporosis; PMR: Rheumatic Polymyalgia; PsA: Psoriatic Arthritis; RA: Rheumatoid Arthritis; RTC: Rheumatology Teleconference; SLE: Systemic Lupus Erythematosus.
a
No exclusive concepts.
b
Several rheumatological processes may concur in the same patient.